4hlw: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
'''Unreleased structure'''
'''Unreleased structure'''


The entry 4hlw is ON HOLD  
The entry 4hlw is ON HOLD until Paper Publication


Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A.
Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A.


Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.
Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.

Revision as of 09:04, 21 November 2012

Unreleased structure

The entry 4hlw is ON HOLD until Paper Publication

Authors: Ravi, S.N.M., Leblanc, E., Axerio-Cilies, P., Labriere, C., Frewin, K., Hassona, M.D.H., Lack, N.A., Han, F.Q., Guns, E.S., Young, R., Ban, F., Rennie, P.S., Cherkasov, A.

Description: Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives.

Proteopedia Page Contributors and Editors (what is this?)

OCA